Skip to main content

Find Clinical Trials

Home
Conditions
High-Risk Cancer

Clinical trial condition

High-Risk Cancer

Explore clinical trials studying High-Risk Cancer. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

High-Risk Cancer trial results

Active, not recruiting

Three Fraction Radiation to Induce Immuno-Oncologic Response

NCT03978663

Conditions: High-Risk Cancer, Locally Advanced Breast Cancer
Locations: London Regional Cancer Program London, Ontario, Canada

View Trial Details

Active, not recruiting

Needs and Preferences of Patients With Head-neck Cutaneous SCC

NCT06046625

Conditions: Behavior, Carcinoma, Carcinoma, Squamous Cell, +23 more
Locations: Maastricht University Medical Center+ Maastricht, Netherlands

View Trial Details

Completed

A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)

NCT05254899

Conditions: Early-stage, Extranodal NK-T-Cell Lymphoma, High-Risk Cancer, +6 more
Locations: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Completed

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer

NCT06908031

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region

NCT05482880

Conditions: Behavior, Carcinoma, Carcinoma, Squamous Cell, +22 more
Locations: Radboud UMC Nijmegen, Gelderland, Netherlands

Maastricht University Medical Center + Maastricht, Limburg, Netherlands

View Trial Details

Completed

Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients

NCT02308280

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada

View Trial Details

Completed

Adjunctive Smart Phone Based Smoking Cessation Treatment

NCT03343249

Conditions: High-Risk Cancer
Locations: Not specified

View Trial Details